Prices & availability of common medicines at six sites in India using a standard methodology

Indian Journal of Medical Research

Volumn 125, Issue 5, 2007, Pages 645-654

  Kotwani, Anita ^a   Ewen, Margaret ^b   Dey, Dalia ^c   Iyer, Shobha ^d   Lakshmi, P K ^e   Patel, Archana ^f   Raman, Kannamma ^g   Singhal, G L ^h   Thawani, Vijay ^f   Tripathi, Santanu ⁱ   Laing, Richard ^j  

^a UNIVERSITY OF DELHI   (India)

^b Vancouver BC   (Netherlands)

^c Faculty Associate   (India)

^d Citizen Consumer and Civic Action Group (CAG)   (India)

^e Karnataka State Pharmacy Council   (India)

^f GOVERNMENT MEDICAL COLLEGE   (India)

^g Association for Consumer Action on Safety and Health   (India)

^h Haryana Govt ^*  (India)

ⁱ INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

HAI methodology; Medicine prices; Private sector; Procurement prices; Public sector; WHO

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; AMOXICILLIN; ARTESUNATE; ATENOLOL; BECLOMETASONE; CAPTOPRIL; CARBAMAZEPINE; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DIAZEPAM; DICLOFENAC; FANSIDAR; FLUCONAZOLE; FLUOXETINE; FLUPHENAZINE DECANOATE; GENERIC DRUG; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; INDINAVIR; LOSARTAN; METFORMIN; MEVINOLIN; NEVIRAPINE; NIFEDIPINE; OMEPRAZOLE; PHENYTOIN; RANITIDINE; UNINDEXED DRUG;

ARTICLE; DRUG COST; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HEALTH CARE POLICY; HUMAN; INDIA; INFORMATION PROCESSING; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PHARMACY; WORLD HEALTH ORGANIZATION;

DRUG COSTS; DRUGS, ESSENTIAL; HEALTH SERVICES ACCESSIBILITY; INDIA; PRIVATE SECTOR; PUBLIC SECTOR;

EID: 34547531306     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Who pays for health systems? World Health Report 2000. Geneva: World Health Organization.
2. Creese A, Kotwani A, Kutzin J, Pillay A. Evaluating pharmaceuticals for health policy in low- and middle-income country settings. In: Freemantle N, Hill S, editors. Evaluating pharmaceuticals for health policy and reimbursement. Massachusetts, USA: Blackwell Publishing (in collaboration with WHO, Geneva); 2004 p. 227-43.
3. Pecoul B, Charac P, Trouiller P, Pinel J. Access to essential drugs in poor countries: a lost battle? JAMA 1999; 281: 361-7.
4. Angell M. The pharmaceutical industry: to whom is it accountable? N Engl J Med 2000; 342: 1902-4.
5. Henry D, Lexchin J. The pharmaceutical industry as a medicines provider. Lancet 2002; 360: 1590-5.
6. Medicine prices - a new approach to measurement. Geneva: World Health Organization and Health Action International. 2003. Available from: www.haiweb.org/medicineprices (accessed on August 28, 2005).
7. Kotwani A. Medicine prices in the state of Rajasthan, India. Survey Report. 2006. Available from http://www.haiweb.org/medicineprices/ surveys/200306IN/survey_report.pdf (accessed on January 3, 2006).
8. India States. Available from: http://www.statoids.com/uin.html (accessed on August 28, 2005).
9. Per capita income of Indian States. Available at: http://www.broadcastindia.com/article2393.html (accessed on August 28, 2005).
10. NPPA. Government of India, National Pharmaceutical Pricing Authority homepage. Available from: http://www.nppaindia.nic.in/index1.html (accessed on August 28, 2005).
11. Human Development Report Maharashtra 2002. Government of Maharashtra, Mumbai. 2002. Available from: http://data.undp.in/shdr/maharashtra/ report.pdf (accessed on August 28, 2005).
12. Madden J. What is a median price ratio? Essential Drug Monitor 2003; 33: 17.
13. Management Sciences for Health. International drug price indicator guide. 2003. Available from: http://erc.msh.org (accessed on August 28, 2005).
14. Laing R. Medicine prices around the world and options for controlling them. Paper presented for the Symposium on Medicine Prices and Availability. Proceedings of the 38th Annual Indian Pharmacological Society Conference; December 28-30, 2005; Chennai: Institute of Pharmacology, Madras Medical College; 2005 p. 20.
15. Madden J, Kotwani A. Availability of essential medicines: an example from Rajasthan, India. Essential Drug Monitor 2003; 33: 17.
16. Delhi Society for Promotion of Rational Use of Drugs (DSPRUD) Activity Report. WHO-India Essential Drugs Programme. Activity Report, January 1998-December 1999. WHO, New Delhi and Delhi Society for Promotion of Rational Use of Drugs.
17. Procurement - Tamil Nadu Medical Service Corporation. Available at: http://tnmsc.tn.nic.in/procurement.htm (accessed on February 10, 2006).
18. Lalitha N. Indian pharmaceutical industry in WTO regime. Econ Polit Wkly 2002; 37: 3542-56.